Search
for
Sort by
Research 301–330 of 1000+
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- DKK3–CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating Strategies
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Broussonetia papyrifera Promotes Hair Growth Through the Regulation of β-Catenin and STAT6 Target Proteins: A Phototrichogram Analysis of Clinical Samples